Long-acting coronary vasodilatory action of the molsidomine metabolite Sin I: a quantitative angiographic study
January 1987
Article
| Related Files |
|---|
|
(1368.pdf, 6.4MB) |
The vasodilatory action of molsidomine was studied by intracoronary injection of its active metabolite, Sin 1. In 10 patients repeat coronary angiography in multiple projections was performed before and 2 minutes after administration of 1 mg of Sin 1, and before and after a second injection 60 minutes later. Contours of obstructed and non-obstructed segments of the left coronary artery were quantitatively analysed with a computer-based angiography analysis system. Immediately after its administration, Sin 1 increased the mean diameters of 44 normal coronary segments by 12% (P less than 0.001). Significant vasodilation (8%) was still observed after 60 minutes. At that time, repeated administration of Sin 1 increased the vasodilation by an additional 14% with respect to the control situation. An increase in obstruction diameter was observed in 6 out of 8 obstructed segments. Mean increase in the minimal obstruction diameter was still 10% after 60 minutes.
- Human
- Support, Non-U.S. Gov't
- Time Factors
- Coronary Angiography
- Injections, Intra-Arterial
- Coronary Vessels/*drug effects
- 0 (Vasodilator Agents)
- 25717-80-0 (Molsidomine)
- 33876-97-0 (3-morpholino-sydnonimine)
- Coronary Disease/*drug therapy/radiography
- Molsidomine/administration & dosage/*analogs & derivatives/therapeutic use
- Vasodilator Agents/administration & dosage/*therapeutic use